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Abstract
Background: Multiplex ligation-dependent probe amplification (MLPA) was originally described as an efficient and 
reliable technique for gene dosage or DNA copy number variation (CNV) analysis. Due to its low cost, reliability, 
sensitivity, and relative simplicity, MLPA has rapidly gained acceptance in research and diagnostic laboratories, and fills 
the gap between genome-wide analysis and single gene analysis. A number of new applications have been developed 
shortly after the introduction of MLPA, including methylation-specific MLPA (MS-MLPA), the use of MLPA in SNP 
genotyping, copy number analysis in segmentally duplicated regions, etc. However, probe design is time consuming 
and error prone. Recently software has been developed to help human genomic MLPA probe selection and 
optimization. For other genomes and MS-MLPA, probe design remains a challenge.
Findings: This paper describes a number of new features added to the previous H-MAPD software, which include: 1) 
probe selection for MS-MLPA; 2) support of mouse and rat genomes; 3) a set of new stuffer sequences. In addition, a 
physical-chemical property verification tool was implemented to verify user defined probes.
Conclusions: MAPD is a web-based tool which is freely available to non-commercial users. The previous H-MAPD 
software has been used by about 200 users from more than 30 countries. With the new features, the author hopes 
MAPD will bring more convenience to the MLPA community.
Findings
Like the original software [1], MAPD supports both elec-
trophoresis-based and bead-coupled MLPA platforms.
The software accepts one or more DNA sequences in
FASTA format. Users should specify the genome (human,
mouse, rat) to be analyzed. Users will also specify the
desired protocol (electrophoresis-based or bead-coupled)
and other experiment parameters (See Additional file 1:
MAPD input page).
Probe selection
For genomic MLPA probe screening, the workflow is sep-
arated into two processes: 1) physical-chemical property
test of hybridizing sequence and oligos; and 2) sequence
uniqueness and variation test (blue and yellow panels in
Figure 1). Different from the original software, adenosine
immediately following left PCR primer will not result in
the drop of the probe set. Also users are allowed to spec-
ify the minimum Tm of hybridizing sequences. Since
probes in which the PCR primer sequence was followed
by an adenosine had a >2-fold lower signal strength [2],
the final score (See Additional file 2: Score calculation for
probe sets) of this type of probe sets will be adjusted by a
factor of 0.5.
For MS-MLPA (See Additional file 3: Diagram of MS-
MLPA), the probe screening inherits all criteria in
genomic MLPA probe design, with an additional restric-
tion enzyme filtering process (orange panel in Figure 1)
[3]. Firstly, one and only one methylation-sensitive
restriction site should be present in the LHS (left hybrid-
izing sequence) and RHS (right hybridizing sequence),
otherwise it will be hard to distinguish which site is
digested. Secondly, the union of stuffer/tag/primer
sequences to the hybridizing sequences may introduce
new recognition sites for the methylation-sensitive
restriction enzyme being used. Some methylation-sensi-
tive restriction enzymes also digest single-stranded DNA
although at a much lower rate. However for methylation
frequency study, this might cause extra error to the result.
Therefore, LPO (left probe oligo) and RPO (right probe
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Figure 1 Outline of probe selection workflow. A successful genomic MLPA probe set needs to meet all the physical-chemical property criteria, and 
pass the uniqueness and variation test. For MS-MLPA, the probe sets need to meet all the restriction enzyme filtering criteria.
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oligo) should not contain extra recognition sites. Thirdly,
at least 4 nt on either side of the restriction site should
still hybridize to the target sequence, because the enzyme
may be less efficient if the restriction site is too close to
the end of the double-stranded region of the probe-target
hybrid [4]. Lastly, in MS-MLPA, a mutation or SNP
within the recognition site of the restriction enzyme
could influence the digestion and might yield false
results. Therefore, probes containing SNP(s) within the
restriction site should also be dropped.
Output
A link will be sent via email to the user upon completion
of the analysis. The result page displays all probe sets
passing genomic MLPA probe design criteria sorted by
scores (See Additional file 4: MAPD result page). A MS-
MLPA filter is incorporated in the result page, and can be
enabled by clicking the 'Enable MS-MLPA Filter' link.
The restriction enzyme recognition site and enzyme
name will be displayed for probe sets that pass the restric-
t i o n  e n z y m e  t e s t  c r i t e r i a  ( S e e  A d d i t i o n a l  f i l e  5 :  M S -
MLPA filter). The methylation-sensitive restriction
enzymes used by MAPD are type II enzymes that cleave
DNA within their recognition sequences. In addition, the
recognition sequences must not contain multiple CpG
dinucleutides (See Additional file 6: Methylation-sensi-
tive restriction enzymes).
Stuffer sequences
The stuffer sequences based on Lambda phage in the
original software was suitable for human genomic MLPA
only. With the software expanded to MS-MLPA and
other genomes, new stuffer sequences need to be
designed with the consideration of multiple genomes and
restriction enzyme recognition sites. A set of new stuffer
sequences has been created based on phage JS98, KVP40,
N4, Phi1, T5 (See Additional file 7: Stuffer sequences). All
stuffer sequences have been verified to meet following
criteria: 1) The union of stuffer sequence and default PCR
primer (used by the commercial MRC-Holland MLPA
kits) should be free of secondary structures; 2) The union
of stuffer sequence and default PCR primer must not
have significant homolog to any of the target genomes
(human, mouse, rat); 3) The union of stuffer sequence
and default PCR primer must not contain restriction sites
for any of the methylation-sensitive restriction enzymes
used by MAPD; 4) No interactions should occur between
different (stuffer sequence + default PCR prime) union
sequences.
Physical-chemical property verification tool
MLPA has been successfully applied in SNP genotyping,
copy number analysis in segmentally duplicated regions
[2,5]. Both applications put the variation at the 3' end of
the LPO. The choices of possible probes are limited, and
manual probe selection is usually sufficient for these
applications. The uniqueness and variation test that
applies to genomic MLPA probe design doesn't apply in
this situation. However, physical-chemical property test
can still be useful by estimating the secondary structure
and melting temperature of probes, and therefore gives
an idea if the probes are likely to succeed. The physical-
chemical property verification tool offers the conve-
nience for multiple probe verification (See Additional file
8: Physical-chemical property verification tool).
Brief discussion
Most MLPA labs use commercial probes from MRC-Hol-
land, or design own probes according to the recommen-
dations of MRC- Holland synthetic probe design protocol
http://www.mlpa.com. MAPD mostly follows MRC- Hol-
land probe design guidelines, with a major difference in
Tm calculation. MRC-Holland recommends RAW pro-
gram to determine Tm, while MAPD uses UNAFold. A
b r i e f  c o m p a r i s o n  o f  T m  c a l c u l a t e d  b y  R A W  a n d
UNAFold is available at http://bioinform.arcan.stony-
brook.edu/mlpa2/help_Tm.html. Users are recom-
mended to verify MAPD results with RAW. MAPD
provides a rich set of stuffer sequences that have been
verified not to interfere with MLPA. With future release
of new assemblies of supported genomes, stuffer
sequences should be verified using new assemblies.
Availability and requirements
MAPD is available at URL http://bioinform.arcan.stony-
brook.edu/mlpa2/cgi-bin/mlpa.cgi. The physical-chemi-
cal property verification tool is available at http://
bioinform.arcan.stonybrook.edu/mlpa2/cgi-bin/probe
Check.cgi. Browsers should have JavaScript enabled.
MAPD software itself is free for all users. However, since
the software utilizes the UCSC genome browser and
UNAFold, commercial users need to obtain a licence for
those programs.
Additional material
Additional file 1 MAPD input page. If the user chooses electrophoresis-
based stuffer protocol, a stuffer sequence select option will be displayed. 
The browser should have Javascript enabled.
Additional file 2 Score calculation for probe sets. The final score for 
each probe set is determined by the scores of Tm, ΔG, GC content and liga-
tion site. Since each individual score falls in the range [0, 1], the final score 
should also fall in range [0, 1], with 1 being the best score. Since probes in 
which the left PCR primer sequence was followed by an adenosine had a 2-
3~ fold lower signal strength, the final score of this type of probe sets will 
be adjusted by a factor of 0.5. Probe sets with a final score > 0 are processed 
for further tests.
Additional file 3 Diagram of MS-MLPA. The principle is similar to 
genomic MLPA except that the sequence detected by MS-MLPA probe con-
tains a recognition sequence for specified methylation-sensitive restriction 
enzyme. Only methylated target will be amplified. Unmethylated target will 
be digested therefore PCR amplification is prevented.Zhi BMC Research Notes 2010, 3:137
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Additional file 4 MAPD result page. All probe sets passing genomic 
MLPA probe design criteria are sorted by their scores. The "View failed 
probe sets" link displays failed probe sets and at which step they fail.
Additional file 5 MS-MLPA filter. Users should select the methylation-
sensitive restriction enzyme, click "Apply Filter" button. The restriction 
enzyme recognition site and enzyme name will be display for probe sets 
that are suitable for MS-MLPA. The browser should have Javascript enabled.
Additional file 6 Methylation-sensitive restriction enzymes. The meth-
ylation-sensitive restriction enzymes used by MAPD are type II enzymes 
that cleave DNA within their recognition sequences. In addition, the recog-
nition sequences must not contain multiple CpG dinucleutides.
Additional file 7 Stuffer sequences. The stuffer sequences (used in elec-
trophoresis-based MPLA) are created based on phage JS98, KVP40, N4, Phi1, 
T5 genome with minor modifications.
Additional file 8 Physical-chemical property verification tool. Screen-
shot of data input page of the physical-chemical property verification tool.
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